- ►annals.org C Natanson, WD Hoffman, AF Suffredini, PQ … - Annals of Internal Medicine, 1994 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Purpose: To review selected new therapies for septic shock designed to ... Cited by 417 - Related articles - BL Direct - All 3 versions
V Lazaron, RA Barke - Urologic Clinics of North America, 1999 - Elsevier The incidence of serious infection in hospitalized patients has increased over
the last 3 decades. These infections have major consequences in morbidity,
mortality, and increased medical expenditures. Particular attention has ... Cited by 16 - Related articles - BL Direct - All 13 versions
F Zeni, B Freeman, C Natanson - Critical care medicine, 1997 - journals.lww.com This issue of Critical Care Medicine reports the results of the second phase III
double-blinded multicenter trial of interleukin-1 receptor antagonist (IL-1ra)
[1] . In a clear presentation and discussion of the data, Dr. Opal and ... Cited by 568 - Related articles - BL Direct - All 4 versions
E Abraham, R Wunderink, H Silverman, TM … - Jama, 1995 - Am Med Assoc OBJECTIVE--To evaluate the efficacy and safety of anti-tumor necrosis factor
alpha monoclonal antibody (TNF-alpha MAb) in the treatment of patients with
sepsis syndrome. DESIGN--Randomized, prospective, multicenter, ... Cited by 580 - Related articles - BL Direct - All 3 versions
CJ Fisher, JM Agosti, SM Opal, SF Lowry, RA … - New England Journal of Medicine, 1996 - content.nejm.org Methods To evaluate the safety and efficacy of TNFR:Fc in the treatment of
septic shock, we conducted a randomized, double-blind, placebo-controlled,
multicenter trial. A total of 141 patients were randomly assigned to ... Cited by 767 - Related articles - BL Direct - All 7 versions
[CITATION] Septic Shock: Mechanisms, Cardiovascular Abnormalities, and New
T Approaches - The Critically Ill Cardiac Patient: Multisystem …, 1996 - Lippincott Williams & Wilkins Related articles
- ►critcaremed.org K Reinhart, C Wiegand-Lohnert, F Grimminger, … - Critical care medicine, 1996 - journals.lww.com From the Department of Anaesthesiology and Operative Intensive Care (Dr.
Reinhart), Friedrich-Schiller-University, Jena, Germany; Steglitz University
Medical Centre (Dr. Wiegand-Lohnert), Berlin, Germany; Department of ... Cited by 245 - Related articles - BL Direct - All 4 versions
ZMN Quezado, SM Banks, C Natanson - Trends in Biotechnology, 1995 - Elsevier Despite the high expectations of scientists and industry, multiple clinical
trials of anti-endotoxin- and anti-cytokine-based therapies for sepsis have
failed to demonstrate benefit. Indeed, in some cases, the agents used were ... Cited by 50 - Related articles - All 5 versions
RL Greenman, RM Schein, MA Martin, RP … - Jama, 1991 - Am Med Assoc OBJECTIVE: To assess the efficacy of adjunctive monoclonal antibody
antiendotoxin immunotherapy in patients with gram-negative sepsis. DESIGN:
Double-blind, randomized, placebo-controlled trial. SETTING: Thirty-three ... Cited by 503 - Related articles - All 3 versions
CJ Fisher Jr, JFA Dhainaut, SM Opal, JP … - Jama, 1994 - Am Med Assoc Charles J. Fisher, Jr, MD; Jean-Francois A. Dhainaut, MD, PhD; Steven M. Opal,
MD; John P. Pribble, PharmD; Robert A. Balk, MD; Gus J. Slotman, MD; Thomas J.
Iberti, MD; Eric C. Rackow, MD; Marc J. Shapiro, MD; Richard L. Greenman, ... Cited by 626 - Related articles - BL Direct - All 4 versions
